Institut fuer Schlaganfall- und Demenzforschung (ISD)

Munich, Bavaria 81377

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early